ArticleBMC cancer2011

Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation.

Jessica E S Bohonowych et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.